chr9-109167260-G-C
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BP4_Strong
The NM_014334.4(FRRS1L):c.-122C>G variant causes a upstream gene change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_014334.4 upstream_gene
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00 AC: 78AN: 150650Hom.: 0 Cov.: 28 FAILED QC
GnomAD3 exomes AF: 0.0000129 AC: 1AN: 77634Hom.: 0 AF XY: 0.0000229 AC XY: 1AN XY: 43750
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000201 AC: 25AN: 1245414Hom.: 0 Cov.: 25 AF XY: 0.0000196 AC XY: 12AN XY: 612886
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.000517 AC: 78AN: 150766Hom.: 0 Cov.: 28 AF XY: 0.000611 AC XY: 45AN XY: 73606
ClinVar
Submissions by phenotype
Developmental and epileptic encephalopathy, 37 Uncertain:2
This sequence change replaces alanine, which is neutral and non-polar, with glycine, which is neutral and non-polar, at codon 11 of the FRRS1L protein (p.Ala11Gly). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with FRRS1L-related conditions. ClinVar contains an entry for this variant (Variation ID: 542863). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. -
Inborn genetic diseases Uncertain:1
The c.32C>G (p.A11G) alteration is located in exon 1 (coding exon 1) of the FRRS1L gene. This alteration results from a C to G substitution at nucleotide position 32, causing the alanine (A) at amino acid position 11 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided Uncertain:1
Not observed at a significant frequency in large population cohorts (Lek et al., 2016); In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at